Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles Annals of Oncology Year : 2019

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

Daniel Pissaloux
  • Function : Author
  • PersonId : 768539
  • IdRef : 17847147X
Isabelle Ray-Coquard
Thomas Bachelot
Sandrine Boyault
  • Function : Author
  • PersonId : 757688
  • IdRef : 075706466

Abstract

Antitumor activity of molecular-targeted agents is guided by the presence of documented genomic alteration in specific histological subtypes. We aim to explore the feasibility, efficacy and therapeutic impact of molecular profiling in routine setting.

Dates and versions

hal-02367110 , version 1 (17-11-2019)

Identifiers

Cite

Olivier Trédan, Qiang Wang, Daniel Pissaloux, Pierre Cassier, Arnaud de La Fouchardière, et al.. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. Annals of Oncology, 2019, 30 (5), pp.757-765. ⟨10.1093/annonc/mdz080⟩. ⟨hal-02367110⟩
154 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More